218 related articles for article (PubMed ID: 28125001)
21. A reversed-phase compatible thin-layer chromatography autography for the detection of acetylcholinesterase inhibitors.
Ramallo IA; García P; Furlan RL
J Sep Sci; 2015 Nov; 38(21):3788-94. PubMed ID: 26489065
[TBL] [Abstract][Full Text] [Related]
22. High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products.
Ingkaninan K; de Best CM; van der Heijden R; Hofte AJ; Karabatak B; Irth H; Tjaden UR; van der Greef J; Verpoorte R
J Chromatogr A; 2000 Mar; 872(1-2):61-73. PubMed ID: 10749487
[TBL] [Abstract][Full Text] [Related]
23. A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants.
Marston A; Kissling J; Hostettmann K
Phytochem Anal; 2002; 13(1):51-4. PubMed ID: 11899607
[TBL] [Abstract][Full Text] [Related]
24. Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii.
Liu YM; Feng YD; Lu X; Nie JB; Li W; Wang LN; Tian LJ; Liu QH
Eur J Med Chem; 2017 Sep; 137():280-291. PubMed ID: 28605675
[TBL] [Abstract][Full Text] [Related]
25. QSAR applications during last decade on inhibitors of acetylcholinesterase in Alzheimer's disease.
Wong KY; Duchowicz PR; Mercader AG; Castro EA
Mini Rev Med Chem; 2012 Sep; 12(10):936-46. PubMed ID: 22303974
[TBL] [Abstract][Full Text] [Related]
26. Screening and determination for potential acetylcholinesterase inhibitory constituents from ginseng stem-leaf saponins using ultrafiltration (UF)-LC-ESI-MS
Yang Y; Liang X; Jin P; Li N; Zhang Q; Yan W; Zhang H; Sun J
Phytochem Anal; 2019 Jan; 30(1):26-33. PubMed ID: 30159954
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease.
Sivaraman B; Raji V; Velmurugan BA; Natarajan R
CNS Neurol Disord Drug Targets; 2022; 21(5):427-449. PubMed ID: 34602041
[TBL] [Abstract][Full Text] [Related]
28. Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity.
Pagliosa LB; Monteiro SC; Silva KB; de Andrade JP; Dutilh J; Bastida J; Cammarota M; Zuanazzi JA
Phytomedicine; 2010 Jul; 17(8-9):698-701. PubMed ID: 19969445
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous screening, identification, quantitation, and activity evaluation of six acetylcholinesterase (AChE) inhibitors in Coptidis Rhizoma by online UPLC-DAD coupled with AChE biochemical detection.
Tan JL; Xu YL; Fei YQ; Zheng GH; Ding XP
J Pharm Biomed Anal; 2022 Sep; 219():114897. PubMed ID: 35780528
[TBL] [Abstract][Full Text] [Related]
30. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
31. A Review on the
de Almeida RBM; de Almeida Luz RLS; Leite FHA; Botura MB
Mini Rev Med Chem; 2022; 22(13):1803-1813. PubMed ID: 34711159
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
[TBL] [Abstract][Full Text] [Related]
33. Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents.
Pourshojaei Y; Eskandari K; Asadipour A
Mini Rev Med Chem; 2019; 19(19):1577-1598. PubMed ID: 31538893
[TBL] [Abstract][Full Text] [Related]
34. Qualitative and quantitative two-dimensional thin-layer chromatography/high performance liquid chromatography/diode-array/electrospray-ionization-time-of-flight mass spectrometry of cholinesterase inhibitors.
Mroczek T
J Pharm Biomed Anal; 2016 Sep; 129():155-162. PubMed ID: 27424196
[TBL] [Abstract][Full Text] [Related]
35. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
Relkin NR
Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
[TBL] [Abstract][Full Text] [Related]
36. Alkaloids from Zephyranthes robusta BAKER and their acetylcholinesterase- and butyrylcholinesterase-inhibitory activity.
Kulhánková A; Cahlíková L; Novák Z; Macáková K; Kuneš J; Opletal L
Chem Biodivers; 2013 Jun; 10(6):1120-7. PubMed ID: 23776027
[TBL] [Abstract][Full Text] [Related]
37. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
38. Allobetulin derived seco-oleananedicarboxylates act as inhibitors of acetylcholinesterase.
Heller L; Schwarz S; Obernauer A; Csuk R
Bioorg Med Chem Lett; 2015 Jul; 25(13):2654-6. PubMed ID: 25980913
[TBL] [Abstract][Full Text] [Related]
39. Acetylcholinesterase Inhibitory Activity of Alkaloids Isolated from Stephania venosa.
Kongkiatpaiboon S; Duangdee N; Prateeptongkum S; Chaijaroenkul W
Nat Prod Commun; 2016 Dec; 11(12):1805-1806. PubMed ID: 30508338
[TBL] [Abstract][Full Text] [Related]
40. Effect directed analysis and TLC screening of Schisandra chinensis fruits.
Sobstyl E; Szopa A; Ekiert H; Gnat S; Typek R; Choma IM
J Chromatogr A; 2020 May; 1618():460942. PubMed ID: 32057448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
